News

Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...
Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built with exactly ...
By Hugo Francisco de Souza A groundbreaking phase 2a study reveals that rentosertib, an AI-developed TNIK inhibitor, could ...
There are 182 clinical trials for Alzheimer’s treatments under way in 2025—an 11% increase on the previous year—testing 138 ...
SHELTON, CT / ACCESS Newswire / June 4, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company ...
Specialist expertise, months of due dilligence, and high conviction investments - KP Rx's formula for healthcare growth ...
The head of the Food and Drug Administration has vowed to conduct a review of the abortion pill as the drug continues to be ...
Discover the major highlights from ASCO 2025, according to researchers and drug developers who attended the convention.
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
After 307 days at CHOP, KJ was dressed in what early studies suggest are the world’s smallest and cutest graduation ...
When executed with precision and transparency, ECAs can enhance trial efficiency, expand access and support evidence—while ...
BeOne Medicines' robust financial outlook is driven by zanubrutinib's rapid sales growth and anticipated positive cash flow.